Cargando…

Explained variation of excess hazard models

The availability of longstanding collection of detailed cancer patient information makes multivariable modelling of cancer‐specific hazard of death appealing. We propose to report variation in survival explained by each variable that constitutes these models. We adapted the ranks explained (RE) meas...

Descripción completa

Detalles Bibliográficos
Autores principales: Maringe, Camille, Pohar Perme, Maja, Stare, Janez, Rachet, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001643/
https://www.ncbi.nlm.nih.gov/pubmed/29633343
http://dx.doi.org/10.1002/sim.7645
_version_ 1783332052464041984
author Maringe, Camille
Pohar Perme, Maja
Stare, Janez
Rachet, Bernard
author_facet Maringe, Camille
Pohar Perme, Maja
Stare, Janez
Rachet, Bernard
author_sort Maringe, Camille
collection PubMed
description The availability of longstanding collection of detailed cancer patient information makes multivariable modelling of cancer‐specific hazard of death appealing. We propose to report variation in survival explained by each variable that constitutes these models. We adapted the ranks explained (RE) measure to the relative survival data setting, ie, when competing risks of death are accounted for through life tables from the general population. RE is calculated at each event time. We introduce weights for each death reflecting its probability to be a cancer death. RE varies between −1 and +1 and can be reported at given times in the follow‐up and as a time‐varying measure from diagnosis onward. We present an application for patients diagnosed with colon or lung cancer in England. The RE measure shows reasonable properties and is comparable in both relative and cause‐specific settings. One year after diagnosis, RE for the most complex excess hazard models reaches 0.56, 95% CI: 0.54 to 0.58 (0.58 95% CI: 0.56–0.60) and 0.69, 95% CI: 0.68 to 0.70 (0.67, 95% CI: 0.66–0.69) for lung and colon cancer men (women), respectively. Stage at diagnosis accounts for 12.4% (10.8%) of the overall variation in survival among lung cancer patients whereas it carries 61.8% (53.5%) of the survival variation in colon cancer patients. Variables other than performance status for lung cancer (10%) contribute very little to the overall explained variation. The proportion of the variation in survival explained by key prognostic factors is a crucial information toward understanding the mechanisms underpinning cancer survival. The time‐varying RE provides insights into patterns of influence for strong predictors.
format Online
Article
Text
id pubmed-6001643
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-60016432018-06-21 Explained variation of excess hazard models Maringe, Camille Pohar Perme, Maja Stare, Janez Rachet, Bernard Stat Med Research Articles The availability of longstanding collection of detailed cancer patient information makes multivariable modelling of cancer‐specific hazard of death appealing. We propose to report variation in survival explained by each variable that constitutes these models. We adapted the ranks explained (RE) measure to the relative survival data setting, ie, when competing risks of death are accounted for through life tables from the general population. RE is calculated at each event time. We introduce weights for each death reflecting its probability to be a cancer death. RE varies between −1 and +1 and can be reported at given times in the follow‐up and as a time‐varying measure from diagnosis onward. We present an application for patients diagnosed with colon or lung cancer in England. The RE measure shows reasonable properties and is comparable in both relative and cause‐specific settings. One year after diagnosis, RE for the most complex excess hazard models reaches 0.56, 95% CI: 0.54 to 0.58 (0.58 95% CI: 0.56–0.60) and 0.69, 95% CI: 0.68 to 0.70 (0.67, 95% CI: 0.66–0.69) for lung and colon cancer men (women), respectively. Stage at diagnosis accounts for 12.4% (10.8%) of the overall variation in survival among lung cancer patients whereas it carries 61.8% (53.5%) of the survival variation in colon cancer patients. Variables other than performance status for lung cancer (10%) contribute very little to the overall explained variation. The proportion of the variation in survival explained by key prognostic factors is a crucial information toward understanding the mechanisms underpinning cancer survival. The time‐varying RE provides insights into patterns of influence for strong predictors. John Wiley and Sons Inc. 2018-04-06 2018-06-30 /pmc/articles/PMC6001643/ /pubmed/29633343 http://dx.doi.org/10.1002/sim.7645 Text en © 2018 The Authors. Statistics in Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Maringe, Camille
Pohar Perme, Maja
Stare, Janez
Rachet, Bernard
Explained variation of excess hazard models
title Explained variation of excess hazard models
title_full Explained variation of excess hazard models
title_fullStr Explained variation of excess hazard models
title_full_unstemmed Explained variation of excess hazard models
title_short Explained variation of excess hazard models
title_sort explained variation of excess hazard models
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001643/
https://www.ncbi.nlm.nih.gov/pubmed/29633343
http://dx.doi.org/10.1002/sim.7645
work_keys_str_mv AT maringecamille explainedvariationofexcesshazardmodels
AT poharpermemaja explainedvariationofexcesshazardmodels
AT starejanez explainedvariationofexcesshazardmodels
AT rachetbernard explainedvariationofexcesshazardmodels